Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 9

    1.

    Alpha-galactosylceramide in chronic hepatitis B infection: results from a randomized placebo-controlled Phase I/II trial.

    Woltman AM, Ter Borg MJ, Binda RS, Sprengers D, von Blomberg BM, Scheper RJ, Hayashi K, Nishi N, Boonstra A, van der Molen R, Janssen HL.

    Antivir Ther. 2009;14(6):809-18.PMID: 19812443 [PubMed - in process]Related articles

    2.

    ALT and viral load decline during PEG-IFN alpha-2b treatment for HBeAg-positive chronic hepatitis B.

    ter Borg MJ, Hansen BE, Bigot G, Haagmans BL, Janssen HL.

    J Clin Virol. 2008 Jun;42(2):160-4. Epub 2008 Mar 24.PMID: 18359663 [PubMed - indexed for MEDLINE]Related articles

    3.

    Modelling of early viral kinetics and pegylated interferon-alpha2b pharmacokinetics in patients with HBeag-positive chronic hepatitis B.

    ter Borg MJ, Hansen BE, Herrmann E, Zeuzem S, Cakaloglu Y, Karayalcin S, Flisiak R, van' t Veen A, de Man RA, Schalm SW, Janssen HL, Haagmans BL; HBV 99-01 Study Group.

    Antivir Ther. 2007;12(8):1285-94.PMID: 18240868 [PubMed - indexed for MEDLINE]Related articles

    4.

    Review article: Success and failure of nucleoside and nucleotide analogues in chronic hepatitis B.

    Leemans WF, Ter Borg MJ, de Man RA.

    Aliment Pharmacol Ther. 2007 Dec;26 Suppl 2:171-82. Review.PMID: 18081660 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Exacerbation of chronic hepatitis B infection after delivery.

    ter Borg MJ, Leemans WF, de Man RA, Janssen HL.

    J Viral Hepat. 2008 Jan;15(1):37-41.PMID: 18088243 [PubMed - indexed for MEDLINE]Related articles

    6.

    Patterns of viral decline during PEG-interferon alpha-2b therapy in HBeAg-positive chronic hepatitis B: relation to treatment response.

    ter Borg MJ, van Zonneveld M, Zeuzem S, Senturk H, Akarca US, Simon C, Hansen BE, Haagmans BL, de Man RA, Schalm SW, Janssen HL; HBV 99-01 Study Group.

    Hepatology. 2006 Sep;44(3):721-7.PMID: 16941701 [PubMed - indexed for MEDLINE]Related articles

    7.

    Low incidence of retinopathy during peginterferon alpha-2b and lamivudine therapy for chronic hepatitis B.

    Buster EH, Ter Borg MJ, Vingerling JR, Janssen HL.

    J Hepatol. 2006 Jul;45(1):160-1; author reply 161-2. Epub 2006 Apr 27. No abstract available. PMID: 16723166 [PubMed - indexed for MEDLINE]Related articles

    8.

    Pegylated interferon-alpha2b and lamivudine in hepatitis B e antigen-positive chronic hepatitis B.

    ter Borg MJ, Janssen HL.

    Ann Intern Med. 2005 Sep 6;143(5):391; author reply 391-2. No abstract available. PMID: 16144900 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Determinants of ambulatory blood pressure response to physical activity.

    Cavelaars M, Tulen JH, van Bemmel JH, ter Borg MJ, Mulder PG, van den Meiracker AH.

    J Hypertens. 2002 Oct;20(10):2009-15.PMID: 12359979 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...